We are live on
!
Find out more
IP
Intellectus Partners Portfolio holdings
AUM
$578M
1-Year Est. Return
49.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.3%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$443M
AUM Growth
+$79.4M
(+22%)
Cap. Flow
+$58.1M
Cap. Flow
% of AUM
13.09%
Top 10 Holdings %
Top 10 Hldgs %
28.62%
Holding
280
New
38
Increased
121
Reduced
93
Closed
8
Avg Time Held Equity + Options
7.3
quarters
Top 10 Avg Time Held Equity + Options
7.5
quarters
Top 20 Avg Time Held Equity + Options
7.9
quarters
Avg Time Held Equity only
7.4
quarters
Top 10 Avg Time Held Equity only
7.5
quarters
Top 20 Avg Time Held Equity only
7.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbCellera Biologics
ABCL
|
+$33.3M |
| 2 |
Lam Research
LRCX
|
+$3.84M |
| 3 |
Strata Critical Medical Inc
SRTA
|
+$1.67M |
| 4 |
iShares Silver Trust
SLV
|
+$1.54M |
| 5 |
Affimed
AFMD
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intellia Therapeutics
NTLA
|
+$1.79M |
| 2 |
Virgin Galactic
SPCE
|
+$1.1M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$947K |
| 4 |
Blackstone
BX
|
+$874K |
| 5 |
IACA
ION Acquisition Corp 1 Ltd.
IACA
|
+$819K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 19.51% |
| 2 | Healthcare | 19.33% |
| 3 | Technology | 19.31% |
| 4 | Consumer Discretionary | 12.84% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Baxter International
BAX
$12.9B
| $433K | 0.1% |
5,361
-2,459
| -31% | -$206K |
2021 Q1
1 quarter
|
|
202
Cognizant
CTSH
$27.6B
| $433K | 0.1% |
6,255
+14
| +0.2% | +$1.04K |
2016 Q4
18 quarters
|
|
203
VanEck Retail ETF
RTH
$243M
| $429K | 0.1% |
2,442
-300
| -11% | -$51.6K |
2020 Q2
4 quarters
|
|
204
DELISTED
Momentus Inc Warrant
MNTSW
| $425K | 0.1% |
+101,259
| New | +$292K |
2021 Q2
0 quarters
|
|
205
Progressive
PGR
$129B
| $421K | 0.09% |
4,283
+5
| +0.1% | +$495 |
2020 Q1
5 quarters
|
|
206
Seagate
STX
$170B
| $408K | 0.09% |
4,642
-1,662
| -26% | -$150K |
2016 Q4
18 quarters
|
|
207
BlackRock Virginia Muni Bond Trust
BHV
$36.4M
| $401K | 0.09% |
22,347
+57
| +0.3% | +$984 |
2019 Q1
9 quarters
|
|
208
State Street Blackstone Senior Loan ETF
SRLN
$5.39B
| $398K | 0.09% |
8,600
-1,000
| -10% | -$46K |
2020 Q4
2 quarters
|
|
209
iShares National Muni Bond ETF
MUB
$48.9B
| $391K | 0.09% |
3,339
-317
| -9% | -$37K |
2019 Q4
6 quarters
|
|
210
Albemarle
ALB
$11.5B
| $388K | 0.09% |
2,300
-54
| -2% | -$8.71K |
2020 Q2
4 quarters
|
|
211
Fiserv Inc
FISV
$24.8B
| $385K | 0.09% |
+3,598
| New | +$418K |
2021 Q2
0 quarters
|
|
212
iShares S&P 500 Growth ETF
IVW
$79.8B
| $381K | 0.09% |
5,236
-460
| -8% | -$31.8K |
2020 Q4
2 quarters
|
|
213
Stanley Black & Decker
SWK
$13.7B
| $374K | 0.08% |
1,825
| – | – |
2020 Q4
2 quarters
|
|
214
First Trust Intermediate Duration Preferred & Income Fund
FPF
$958M
| $369K | 0.08% |
+14,677
| New | +$362K |
2021 Q2
0 quarters
|
|
|
KRBP
215
DELISTED
Kiromic BioPharma, Inc. Common Stock
KRBP
| $360K | 0.08% |
2,497
+1,225
| +96% | +$307K |
2020 Q4
2 quarters
|
|
|
ALXN
216
DELISTED
Alexion Pharmaceuticals
ALXN
| $357K | 0.08% |
1,942
-342
| -15% | -$58.7K |
2020 Q1
5 quarters
|
|
217
Snowflake
SNOW
$126B
| $350K | 0.08% |
1,446
-280
| -16% | -$65.1K |
2021 Q1
1 quarter
|
|
218
iShares MBS ETF
MBB
$35.7B
| $348K | 0.08% |
3,212
-714
| -18% | -$77.4K |
2019 Q1
9 quarters
|
|
219
Quadratic Interest Rate Volatility and Inflation Hedge ETF
IVOL
$221M
| $345K | 0.08% |
12,500
+2,000
| +19% | +$56.9K |
2021 Q1
1 quarter
|
|
220
iShares Semiconductor ETF
SOXX
$45B
| $345K | 0.08% |
2,280
| – | – |
2021 Q1
1 quarter
|
|
221
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$121M
| $342K | 0.08% |
+726
| New | +$433K |
2021 Q2
0 quarters
|
|
222
Check Point Software Technologies
CHKP
$13.8B
| $334K | 0.08% |
2,878
| – | – |
2021 Q1
1 quarter
|
|
223
BlackRock Resources & Commodities Strategy Trust
BCX
$941M
| $328K | 0.07% |
+34,815
| New | +$334K |
2021 Q2
0 quarters
|
|
224
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.9B
| $328K | 0.07% |
1,131
+1
| +0.1% | +$280 |
2021 Q1
1 quarter
|
|
225
TJX Companies
TJX
$156B
| $325K | 0.07% |
4,819
+300
| +7% | +$20.5K |
2016 Q4
18 quarters
|
|
Similar funds
AFGAS
RWM
AHL
CTAF
HIM
SSP
CA
PWM
Intellectus Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Intellectus Partners held 280 positions worth $443M, up 22% from $364M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Intellectus Partners deployed $58.1M of net new capital in Q2 2021, opening 38 new positions and adding to 121 existing holdings. Its largest new stake was AbCellera Biologics: 1,206,979 shares worth $26.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Intellia Therapeutics, an estimated $1.79M trimmed.
- Intellectus Partners's largest Q2 2021 buy was AbCellera Biologics: 1,206,979 shares worth $26.6M.
- Intellectus Partners added most to iShares Silver Trust in Q2 2021, an estimated $1.54M increase.
- Intellectus Partners's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $1.79M.
- Intellectus Partners fully exited Virgin Galactic in Q2 2021, selling an estimated $1.1M.
- Intellectus Partners's ten largest holdings make up 29% of its $443M portfolio in Q2 2021.
- Intellectus Partners opened 38 new positions and closed 8 in Q2 2021.
- Intellectus Partners's portfolio value rose 22% quarter-over-quarter to $443M.
Based on Intellectus Partners's 13F filing for Q2 2021, filed 13 Aug 2021.